Figure . Assessment and Treatment of Severe Asthma, According to Inflammatory Phenotypes, in Patients without a Response to Core Multidisciplinary Management. Eligibility for omalizumab includes an IgE level of at least 30 IU per m...
In addition, it must be acknowledged that so far no effective strategies are available for patients with non-eosinophilic asthma and further research and development is necessary for this patient group.Keywords: asthma therapy, monoclonal antibodies, pharmacological treatment, severe asthma, ...
The development of monoclonal antibody therapies targeting specific components of the pathways relevant to asthma pathophysiology has revolutionized treatment of severe asthma both in adults and children and helped to further unravel the heterogeneity of this disease. However, the availability of multiple ag...
ES3-2 Stratified or Personalised Approaches to the Treatment of Severe Asthma 来自 Semantic Scholar 喜欢 0 阅读量: 3 作者: S Holgate 年份: 2010 收藏 引用 批量引用 报错 分享 全部来源 求助全文 Semantic Scholar 0关于我们 百度学术集成海量学术资源,融合人工智能、深度学习、大数据分析等技术,为科研...
Around five million people in the UK are currently being treated for asthma. Of these, a quarter of a million are unable to get good control of their condition, resulting in frequent, severe, or even life-threatening attacks. A new study brings hope to t
lung function. Short-acting beta-agonists are used for quick relief of symptoms during an asthma attack, while montelukast is an alternative medication that can be used in combination with ICS. Long-acting beta-agonists are typically used in combination with ICS for more severe cases of asthm...
Omalizumab is relatively well tolerated, and only rarely induces anaphylactic reactions. Therefore, this drug represents a valid option as add-on therapy for patients with severe persistent allergic asthma, inadequately controlled by high doses of standard inhaled treatments. 展开 ...
The immune response that occurs in patients with severe asthma is markedly different than what occurs in milder forms of the lung condition, according to researchers from the University of Pittsburgh School of Medicine. Those unique features could point
Study: severe asthma fails to respond to mainstay treatmentmntJournal of Clinical Investigation
Disease Management Approaches to Asthma: What Does it Mean for the Patient? Reviews-on-treatmentDespite an increased understanding of the pathophysiology of asthma and effective therapies, the prevalence, morbidity and mortality of ... George,M. - 《Disease Management & Health Outcomes》 被引量: ...